April 3, 2025 - 07:44

A troubling trend has emerged among newly diagnosed type 2 diabetes patients, as nearly 40% are reported to stop their medication within the first year. Experts from UVA Health have highlighted this alarming statistic in a recent publication, emphasizing the potential health risks associated with such decisions.
Discontinuing prescribed diabetes medications can lead to serious complications, including increased blood sugar levels and a higher risk of cardiovascular diseases. The findings suggest that many patients may not fully understand the importance of their treatment regimen or may face barriers that prevent them from adhering to their prescribed medications.
Health professionals are urged to engage in more comprehensive discussions with their patients about the necessity of continuous treatment and the consequences of non-compliance. Strategies to improve patient education and support systems are essential to ensure that individuals diagnosed with type 2 diabetes remain committed to their health management plans. This shift could significantly enhance patient outcomes and reduce the long-term impact of the disease.
July 18, 2026 - 01:20
State of the Lake presentation discusses Tahoe’s health in a warming worldTAHOE CITY, Calif. - Fifty years ago this July, Tahoe Environmental Research Center founder Charles R. Goldman launched the John Le Conte onto Lake Tahoe. That vessel is still in use today, marking...
July 17, 2026 - 09:59
MDCalc is scoring the clinical calculators used by millions of doctorsMDCalc, a widely used online platform for medical reference, is rolling out a new quality-rating system for its library of over 800 clinical calculators. These tools help physicians assess...
July 16, 2026 - 22:30
Long Sleep Hours Linked to Higher Alzheimer's Protein Levels, UT Health San Antonio Study FindsA new study from UT Health San Antonio has uncovered a concerning connection between sleeping long hours and increased levels of a protein associated with Alzheimer`s disease. Researchers found...
July 16, 2026 - 04:31
University of Michigan’s David C. Miller chosen to succeed Jeff Balser as Vanderbilt Health’s President and CEO and Dean of Vanderbilt University School of MedicineDavid C. Miller, MD, MPH, has been selected as the next President and Chief Executive Officer of Vanderbilt Health and Dean of the Vanderbilt University School of Medicine. Miller currently serves...